These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

461 related items for PubMed ID: 21860282

  • 1. Cervicovaginal cytology in the detection of recurrence after cervical cancer treatment.
    Rimel BJ, Ferda A, Erwin J, Dewdney SB, Seamon L, Gao F, DeSimone C, Cotney KK, Huh W, Massad LS.
    Obstet Gynecol; 2011 Sep; 118(3):548-553. PubMed ID: 21860282
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Follow-up testing after colposcopy: five-year risk of CIN 2+ after a colposcopic diagnosis of CIN 1 or less.
    Katki HA, Gage JC, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Kinney WK.
    J Low Genit Tract Dis; 2013 Apr; 17(5 Suppl 1):S69-77. PubMed ID: 23519308
    [Abstract] [Full Text] [Related]

  • 4. Pooled analysis on the necessity of random 4-quadrant cervical biopsies and endocervical curettage in women with positive screening but negative colposcopy.
    Hu SY, Zhang WH, Li SM, Li N, Huang MN, Pan QJ, Zhang X, Han Y, Zhao FH, Chen W, Qiao YL.
    Medicine (Baltimore); 2017 Apr; 96(17):e6689. PubMed ID: 28445270
    [Abstract] [Full Text] [Related]

  • 5. "See and treat" approach is appropriate in women with high-grade lesions on either cervical cytology or colposcopy.
    Aue-Aungkul A, Punyawatanasin S, Natprathan A, Srisomboon J, Kietpeerakool C.
    Asian Pac J Cancer Prev; 2011 Apr; 12(7):1723-6. PubMed ID: 22126552
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
    Evans MF, Adamson CS, Papillo JL, St John TL, Leiman G, Cooper K.
    Cancer; 2006 Mar 01; 106(5):1054-64. PubMed ID: 16421920
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Results of pap smears and immunocytochemical detection of the p16 and Ki67 proteins in women with cervical intraepithelial neoplasia and cervical cancer].
    Rokita W, Skawiński D, Zmelonek-Znamirowska A, Kedzia W, Karowicz-Bilińska A, Spaczyński R, Spaczyński M.
    Ginekol Pol; 2012 Nov 01; 83(11):822-6. PubMed ID: 23379189
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic value of endocervical curettage for detecting dysplastic lesions in women with atypical squamous cells of undetermined significance (ASC-US) and low grade squamous intraepithelial lesion (LSIL) Papanicolaou smears.
    Poomtavorn Y, Suwannarurk K, Thaweekul Y, Maireang K.
    Asian Pac J Cancer Prev; 2014 Nov 01; 15(8):3461-4. PubMed ID: 24870740
    [Abstract] [Full Text] [Related]

  • 12. Defining the Longitudinal Risk of CIN 3+ for <CIN 2 Colposcopy for Patients Referred With High-Grade Cytology.
    Piedimonte S, Tsang K, Jembere N, Murphy J, Karapetian T, Gao J, McCurdy B, Sacco J, Kupets R.
    J Low Genit Tract Dis; 2024 Jan 01; 28(1):7-11. PubMed ID: 37906611
    [Abstract] [Full Text] [Related]

  • 13. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
    Safaeian M, Wright TC, Stoler MH, Ranger-Moore J, Rehm S, Aslam S, Fang Q, Volkir P, Ridder R.
    Am J Obstet Gynecol; 2021 Sep 01; 225(3):278.e1-278.e16. PubMed ID: 33852886
    [Abstract] [Full Text] [Related]

  • 14. Utility of p16 Immunohistochemistry in Evaluating Negative Cervical Biopsies Following High-risk Pap Test Results.
    Shain AF, Kwok S, Folkins AK, Kong CS.
    Am J Surg Pathol; 2018 Jan 01; 42(1):69-75. PubMed ID: 29112019
    [Abstract] [Full Text] [Related]

  • 15. The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer.
    Castle PE, Fetterman B, Thomas Cox J, Shaber R, Poitras N, Lorey T, Kinney W.
    Obstet Gynecol; 2010 Jul 01; 116(1):76-84. PubMed ID: 20567171
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Outcome of "Atypical squamous cells" in a cervical cytology screening program: implications for follow up in resource limited settings.
    Gupta S, Sodhani P, Chachra KL, Singh V, Sehgal A.
    Diagn Cytopathol; 2007 Nov 01; 35(11):677-80. PubMed ID: 17924415
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Management of abnormal cervical cytology screening in adolescent and young women in a canadian colposcopy centre: a descriptive analysis.
    Bouchard-Fortier G, Paszat L, Murphy KJ.
    J Obstet Gynaecol Can; 2013 Feb 01; 35(2):149-55. PubMed ID: 23470065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.